Mintz attorney Adam Falconi has been appointed Chair of the Life Sciences Sector for Licensing Executives Society (USA & Canada), Inc. (LES). 

LES is the original, leading professional society for intellectual property and licensing experts. The group brings IP and licensing groups together to network, collaborate and discuss some of the most critical issues facing the industry today and tomorrow.

Adam is a Chambers-ranked lawyer who focuses his practice on corporate law, financing, and technology transactions in the life sciences and health technology industries. His clients include a wide range of life science and health care companies, as well as venture capital and private equity funds.

Adam has a specific focus on strategic partnering and commercialization for pharmaceutical, biotechnology, and medical device companies. He frequently advises on complex licensing, strategic collaborations, venture capital, mergers and acquisitions, and intellectual property transactions and helps his clients develop, scale, and commercialize their technologies in Canada, the United States, and other countries around the world.

About Licensing Executives Society (USA & Canada), Inc. (LES)

Established in 1965, LES (USA & Canada) is one of the longest running professional societies supporting the development of members engaged in the creation, commercial development, and orderly transfer of intellectual property. LES members include business executives, lawyers, accountants, consultants, and scientists and engineers; who represent innovation-oriented enterprises of all sizes, professional services firms, universities, and government labs. LES is the largest of 43 global member societies of the Licensing Executives Society International, Inc. (LESI). For more information about LES, visit www.lesusacanada.org.